• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Ajooni Share Price

    Ajooni Biotech Share PriceAjooni Biotech

    Small Cap Result
    ₹4.75
    -0.1 (-2.06%)
    As on 02 December, 2023 | 21:43 BSE: NSE: AJOONIISIN: INE820Y01021
    Bonus Split

    Ajooni Biotech Performance

    Day Range

    • Low 4.75
    • High 4.90
    ₹ 4.75

    52 Week Range

    • Low 3.05
    • High 7.95
    ₹ 4.75
    • Open Price4.90
    • Previous Close4.85
    • Volume477595

    Start SIP in Ajooni Biotech

    Start SIP

    Ajooni Biotech Share Price

    • Over 1 Month -3.06%
    • Over 3 Month 13.1%
    • Over 6 Month 3.26%
    • Over 1 Year -36.24%

    Ajooni Biotech Key Statistics

    P/E Ratio 28.6
    PEG Ratio 0.4
    Market Cap Cr 42
    Price to Book Ratio 1
    EPS 0.1
    Dividend 0
    Relative Strength Index 49.17
    Money Flow Index 39.18
    MACD Signal 0.06
    Average True Range 0.2

    Ajooni Biotech Investment Rating

    • Master Rating:

    • Ajooni Biotech has an operating revenue of Rs. 92.37 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 23 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 138 indicates it belongs to a poor industry group of Agricultural Operations and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Ajooni Biotech Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 19214111101221
    Operating Expenses Qtr Cr 19204010101220
    Operating Profit Qtr Cr 1110110
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 0010000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 7574
    Operating Expenses Annual Cr 7271
    Operating Profit Annual in Cr 33
    Depreciation Cr 11
    Interest Annual Cr 01
    Tax Annual Cr 00
    Net Profit Annual Cr 11
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 4
    Cash from Investing Activity Annual Cr -2
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 4216
    Fixed Assets Annual Cr 76
    Total Non Current Assets Annual Cr 247
    Total Current Assets Annual Cr 3522
    Total Assets Annual Cr 5929
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 516
    ROE Annual % 36
    ROCE Annual % 511
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 44
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Ajooni Biotech

    Ajooni Biotech Technicals

    EMA & SMA

    Current Price
    ₹4.75
    -0.1 (-2.06%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹4.80
    • 50 Day
    • ₹4.69
    • 100 Day
    • ₹4.67
    • 200 Day
    • ₹5.08
    • 20 Day
    • ₹4.82
    • 50 Day
    • ₹4.68
    • 100 Day
    • ₹4.48
    • 200 Day
    • ₹4.63

    Ajooni Biotech Resistance and Support

    PIVOT
    ₹4.8
    Resistance
    First Resistance 4.85
    Second Resistance 4.95
    Third Resistance 5.00
    RSI 49.17
    MFI 39.18
    MACD Single Line 0.06
    MACD 0.05
    Support
    First Resistance 4.70
    Second Resistance 4.65
    Third Resistance 4.55

    Ajooni Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 477,595 23,316,188 48.82
    Week 543,437 38,029,704 69.98
    1 Month 527,577 33,015,790 62.58
    6 Month 542,665 39,250,935 72.33

    Ajooni Biotech Result Highlights

    Ajooni Biotech Synopsis

    NSE-Agricultural Operations

    Ajooni Biotech Ltd. belongs to the Industry of Livestock - Hatcheries/Poultry. Company’s Total Operating Revenue is Rs. 74.49 Cr. and Equity Capital is Rs. 17.52 Cr. for the Year ended 31/03/2023. Ajooni Biotech Ltd. is a Public Limited Listed company incorporated on 17/02/2010 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L85190PB2010PLC040162 and registration number is 040162.
    Market Cap 42
    Sales 92
    Shares in Float 6.40
    No of funds
    Yield
    Book Value 1
    U/D Vol ratio 0.7
    LTDebt / Equity 4
    Alpha -0.17
    Beta 1.48

    Ajooni Biotech

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 27.46%30.28%36.39%36.39%
    Mutual Funds
    Insurance Companies
    Foreign Portfolio Investors 0.01%0.01%
    Financial Institutions/ Banks
    Individual Investors 63.05%59.95%54.97%52.09%
    Others 9.49%9.77%8.63%11.51%

    Ajooni Biotech Management

    Name Designation
    Mr. Ramandeep Singh Independent Director
    Mr. Imteshwar Singh Independent Director
    Ms. Simmi Chabbra Independent Woman Director
    Mr. Jasjot Singh Managing Director
    Mr. Partek Singh Director

    Ajooni Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Ajooni Biotech Corporate Action

    Date Purpose Remarks
    2023-11-09 Quarterly Results
    2023-08-03 Quarterly Results
    2023-05-18 Audited Results
    2023-02-14 Quarterly Results
    2022-11-11 Quarterly Results
    Date Purpose Remarks
    2021-03-12 Bonus Rs.0.00 issue in the ratio of 1:9 of Rs. 10/-.
    Date Purpose Remarks
    2022-10-07 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

    Ajooni Biotech FAQs

    What is Share Price of Ajooni Biotech ?

    Ajooni Biotech share price is ₹4 As on 02 December, 2023 | 21:29

    What is the Market Cap of Ajooni Biotech ?

    The Market Cap of Ajooni Biotech is ₹41.6 Cr As on 02 December, 2023 | 21:29

    What is the P/E ratio of Ajooni Biotech ?

    The P/E ratio of Ajooni Biotech is 28.6 As on 02 December, 2023 | 21:29

    What is the PB ratio of Ajooni Biotech ?

    The PB ratio of Ajooni Biotech is 1 As on 02 December, 2023 | 21:29

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.